Skip to content
Innovex Therapeutics
  • Home
  • R&D
    • Vaccine against Plasmodium vivax malaria
    • Vaccine against Covid-19
    • Vaccine against PRRSV
  • About Us
    • The company
    • Our Story
    • The Team
    • Advisory board
  • News
  • Contact Us
  • Home
  • R&D
    • Vaccine against Plasmodium vivax malaria
    • Vaccine against Covid-19
    • Vaccine against PRRSV
  • About Us
    • The company
    • Our Story
    • The Team
    • Advisory board
  • News
  • Contact Us
Innovex Therapeutics
  • Home
  • R&D
    • Vaccine against Plasmodium vivax malaria
    • Vaccine against Covid-19
    • Vaccine against PRRSV
  • About Us
    • The company
    • Our Story
    • The Team
    • Advisory board
  • News
  • Contact Us
  • Home
  • R&D
    • Vaccine against Plasmodium vivax malaria
    • Vaccine against Covid-19
    • Vaccine against PRRSV
  • About Us
    • The company
    • Our Story
    • The Team
    • Advisory board
  • News
  • Contact Us

CSO of ITSL Coordinates a National Network of REDiEX

CSO of ITSL Coordinates a National Network of Excellenc in Research and Innovation on Exosomes (REDiEX) funded by MINECO.

Continue reading

CSO named President of GEIVEX

CSO named President of the Spaniard Research group on Research and Development on Extracellular Vesicles (GEIVEX)

Continue reading

Recent Posts

  • The Plasmodium vivax malaria project of ITSL elected as part the fund’s portfolio of the EU Malaria Fund
  • Plasmodium vivax: the Neglected Malaria
  • Dr. Agustin Arasanz Duque named new Interim CEO of ITSL
  • RIS3CAT Project
  • New shareholders

Search Content

Navigation

  • Home
  • R&D
    • Vaccine against Plasmodium vivax malaria
    • Vaccine against Covid-19
    • Vaccine against PRRSV
  • About Us
    • The company
    • Our Story
    • The Team
    • Advisory board
  • News
  • Contact Us

Today’s Choice

Follow Us

DribbbleSpotifySteamWeiboPinterest
Innovex Therapeutics
Innovex Therapeutics S.L. is a biotechnology company that uses Extracellular Vesicles as Vaccines against infectious diseases with the goal of global health equity.
Linkedin